Blood Sample Donations to Study the Role of Genes in Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

320 participants

Study Classification

OBSERVATIONAL

Study Start Date

2002-12-10

Study Completion Date

2010-03-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study attempts to identify genes that may increase or decrease the likelihood of sciatic pain (shooting pain down the leg) persisting 1 year after treatment of a herniated spinal disc. Many proteins in the nerves, spinal cord, and brain are involved in processing pain. These proteins vary slightly in different people. Animal studies have shown that rats and mice with certain types of proteins experience chronic pain after sciatic injury while those with other types do not. Better information about the role of genes in pain processing may lead to a test for the risk of chronic pain for specific individuals and more effective treatment approaches.

This study will include people who participated in the Maine Lumbar Pain Study of the natural history of spinal pain. The Maine study included patients treated for sciatic pain caused by a herniated disc. In this study, patients who did not improve with medical treatment were referred for surgery to remove the disc. Of those referred for surgery, 275 elected to have the operation, and 232 did not. One year after surgical consultation, leg pain was reduced in 81 percent of patients who underwent surgery. Of those who declined surgery, 56 percent improved after 1 year. This study will look for genetic differences in the non-surgical group that might reveal differences among those who improved and those who did not.

Participants will provide a blood sample (approximately 2 tablespoons) for genetic testing. They will also provide information on the ethnic background of their parents and grandparents. Different gene variants occur in different ethnic groups, so information on ethnic background will help researchers know what gene variants to look for. Participants will complete a questionnaire about their smoking history, because the same protein in the brain that responds to nicotine may also play a part in decreasing or increasing pain. Also, some surgeons believe that smoking can interfere with spinal bone healing. Information from this study will help resolve this question.

...

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Exploring the Genetics of Neuropathic Pain

NCT03862365

Neuropathic Pain Genetic Predisposition Polyneuropathies

RECRUITING

Characterization of Phenotypic and Genotypic Regressors for Imaging

NCT01148381

Healthy Volunteers Substance Use Disorders

COMPLETED

Pain Predict Genetics

NCT02383342

Chronic Pain Acute Pain

RECRUITING

Study to Identify the Genetic Variations Associated With Phantom Limb Pain

NCT01462448

Phantom Limb

COMPLETED

Genetic Architecture of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

NCT06325878

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Many patients have persistent pain one year after herniated lumbar disc even when the disc is surgically removed or shrinks spontaneously. We hypothesize that the risk of persistent pain is modified by common variations in genes related to inflammation and pain processing. We propose to collect blood for DNA analysis from up to 500 patients who have been followed for 10 years after the onset of severe sciatica in the Maine Lumbar Spine Study. Based on the pain research literature, Human Genome databases, and gene studies in NIAAA's Laboratory of Neurogenetics, we will prioritize approximately 100 candidate genes with variants that affect the function of their proteins. We will type patients' DNA for these variants and compare their clinical data with their genotype at each candidate gene to see if common variants increase or decrease the risk of chronic pain. The primary phenotype variable will be the amount of persistent leg pain one year after pain onset, Identification of such associations, if replicated in future studies, may help to prioritize targets for drug treatments or identify genetic tests that can predict the prognosis of acute sciatica and assist in treatment choice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Presented to Maine orthopedic or neurosurgeon approximately 10 years ago with complaint of sciatica and was enrolled in Maine Lumbar Spine Study.

Outcome dataset includes ratings of low back and leg pain at baseline and at least one followup evaluation.

Eligible Sex

ALL

Accepts Healthy Volunteers

No